Duos Technologies Group (DUOT) director reports multiple stock awards

Rhea-AI Filing Summary

Duos Technologies Group director Ned Mavrommatis reported stock awards rather than open-market trades. On 2025-12-31, he acquired 1,748 shares of common stock as compensation for his services as a director. A separate 10,000-share grant was also reported at a reference price of $11.4438 per share.

The amended filing states this 10,000-share grant corrects the original issue date and price. These 10,000 shares were granted under the company’s 2021 Equity Incentive Plan and are subject to a one-year cliff, with all shares vesting on April 1, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MAVROMMATIS NED

(Last) (First) (Middle)

7660 CENTURION PARKWAY

SUITE 100

(Street)

JACKSONVILLE FL 32256

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DUOS TECHNOLOGIES GROUP, INC. [ DUOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
01/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value	12/31/2025		A(1)		1,748	A	$11.4438	40,896	D
Common Stock, $0.001 par value	12/31/2025		A(1)(2)		10,000	A	$11.4438	50,896	D
Common Stock, $0.001 par value								10,000(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were issued to Mr. Mavrommatis as compensation shares for his services as a Director of the Issuer.

2. This amendment corrects the issue date and price of this 10,000 share grant.

3. These shares were granted to Mr. Mavrommatis pursuant to the Issuer's 2021 Equity Incentive Plan, as amended, and are subject to a one-year cliff vesting period. All of the shares vest on April 1, 2026.

	/s/ Ned Mavrommatis	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did DUOT director Ned Mavrommatis report on this Form 4/A?

Ned Mavrommatis reported acquiring Duos Technologies Group common stock through equity awards, not market purchases. One award covers 1,748 shares as director compensation, and another covers 10,000 shares granted under the 2021 Equity Incentive Plan at a reference price of $11.4438 per share.

Were the DUOT insider transactions open-market buys or stock grants?

The DUOT transactions were stock grants, not open-market buys. Both are coded as awards or other acquisitions, including 1,748 compensation shares and a separate 10,000-share grant. They reflect equity-based compensation and plan awards rather than cash purchases of Duos Technologies Group stock.

What does the amended 10,000-share grant for DUOT correct?

The amendment corrects the issue date and price of a 10,000-share grant. The filing explains that this equity award to Ned Mavrommatis is being restated to reflect the accurate grant date and reference price, while keeping the number of Duos Technologies Group shares at 10,000.

When do the 10,000 DUOT equity incentive shares vest for Ned Mavrommatis?

The 10,000 Duos Technologies Group shares granted under the 2021 Equity Incentive Plan use a one-year cliff vesting schedule. According to the filing, all of these shares vest on April 1, 2026, meaning no portion vests earlier and the full grant vests at that date.

Under which plan were the 10,000 DUOT shares granted to the director?

The 10,000-share award to Ned Mavrommatis was granted under Duos Technologies Group’s 2021 Equity Incentive Plan, as amended. The filing notes that this grant is subject to the plan’s terms and carries a one-year cliff vesting period, with full vesting on April 1, 2026.

Why were 1,748 DUOT shares issued to Ned Mavrommatis?

The 1,748 Duos Technologies Group shares were issued as compensation for Ned Mavrommatis’s services as a director. The filing states these are compensation shares, reflecting part of his board remuneration paid in stock rather than cash, aligning director pay with shareholder interests.